H2020Индивидуална стипендия2017–2019

NEUROMODEL · Statistical Modelling for relating multimodal neuroimaging to clinical outcomes in order to predict patient response to depression therapy.

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2017-06-01 → 2019-05-31
Финансиране от ЕС
200 195 €
Участници
1
Схема
MSCA-IF-EF-ST

Линиите свързват координатора с партньорите.

Накратко на български

Статистически модели анализират връзката между изображения на мозъка и нивата на серотонин, за да предвидят как пациенти с депресия ще реагират на терапия. Това помага за подобряване на превенцията и лечението на мозъчни разстройства.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Statistical Modelling for relating multimodal neuroimaging to clinical outcomes in order to predict patient response to depression therapy.

Understanding brain mechanisms and how they are affected by pharmacological interventions is essential to improve prevention and treatment of brain disorders. For instance, in major depressive disorders (MDD), less than half of the patients respond to first-line antidepressant treatment and previous attempts to identify a single biomarker that can critically predict individualized treatment response have so far failed. It has been hypothesized that the serotonin system is a key factor in MDD and most antidepressants attempt to act on this system. Recent advances in medical imaging allow to simultaneously visualize the brain structure (using Magnetic Resonance Imaging - MRI) and the serotonin system (using Positron Emission Tomography - PET) in order to characterize the role of serotonin in MDD and antidepressant therapy, e.g. to determine whether an abnormal serotonin levels make the patient more likely to respond to antidepressive treatment. This is being investigating in research project called Neuropharm (https://np.nru.dk/) conducted in Copenhagen, Denmark. The aim of this project is to provide the statistical tools to successfully analyze complex data mixing brain images, clinical, psychological, and genetic data. Latent variable models (LVMs), a multivariate technique using latent variables to model the relationship between indirect measurements of quantities of interest (e.g., of the brain serotonin level and the depression status of the patient), are of particular interest but need to be adapted to the context of neuroscience. Because PET and MRI measurement are expensive, studies involve a limited number of individuals (typically less than 100) and are intended to investigate several hypotheses. This is a challenge for the validity of the statistical analysis since traditional results holds in large samples and for a single hypothesis. Moreover due to the complexity of the brain system, it is difficult to specify a priori a valid statistical model. Efficient model-selection procedures need to be developed for LVMs. To ensure the diffusion of the methods to neuroscientists, the project also aimed at making the proposed statistical tools publicly available, with appropriate documentation, and assisting neuroscientists in their use.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Every year, 1 out of 15 Europeans suffer from major depression (MDD) and MDD is the third cause of Disability-adjusted life-years. Today, the available treatments are clearly insufficient; only about 50% of MDD patients respond to drug intervention. We here posit that identification of biomarkers that can predict treatment response is needed to adapt a personalized medicine approach, and most likely this will involve not a single outcome but a combination of multimodal brain imaging outcomes, psychological, genetic, and environmental data. The complexity of such data requires a complex statistical model that currently does not exist. Thus, my aim is to develop a new flexible statistical method that can take into account heterogeneous types of data. More specifically, I will develop a fully flexible Latent Variable Model (LVM) that can deal with high dimensional measurements (e.g. images), non-Gaussian variables, and non-linear relationships. I will apply this flexible LVM on existing data from depressed and healthy individuals and later expand the application to predict treatment outcomes. The latter data are currently acquired and includes a cohort of MDD patients treated with a selective serotonin reuptake inhibitor (SSRI), followed in a longitudinal design. The chosen host institution is perfectly situated to this project, as they have an established unique database including, e.g., functional Magnetic Resonance Imaging (fMRI), high resolution Positron Emission Tomography (PET), and neuropsychological test outcomes. This research project uniquely combines advanced statistical modelling of rich data sets with the ultimate aim to establish individualized depression therapy. Moreover, it forms a foundation for a more general approach to integrate brain neurobiology in terms of imaging outcomes with other patient-specific data.

Оригинален текст от CORDIS (на английски).

Участници

  • REGION HOVEDSTADEN · HillerodКоординаторДания

Връзки

Данни: CORDIS, © Европейски съюз